Ad
related to: cetuximab premedication protocol pdf version download free pc 1 19 windows 10- Patient Self-Care Kit
Skin & Nail Care Info. Learn How to
Order The Patient Self Care Kit.
- ERBITUX® (cetuximab)
HCPs View Prescribing, Dosing, &
Important Safety Information Here.
- Financial Assistance Info
See If Your Patients Are Eligible
For Our Reimbursement Program.
- Dose Modification Info
View Dosing Info Related to Side
Effects Of ERBITUX® (cetuximab).
- Patient Self-Care Kit
Search results
Results From The WOW.Com Content Network
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. [2] Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion .
Cetuximab (trade name: Erbitux ) is a recombinant chimeric monoclonal antibody designed to treat metastatic colorectal cancer and head and neck cancer. [14] In numerous cancers, the epidermal growth factor receptor (EGFR) is often inappropriately activated and overexpressed in cancer cells, leading to uncontrolled cell growth. [ 15 ]
Premedication is using medication before some other therapy (usually surgery or chemotherapy) to prepare for that forthcoming therapy. Typical examples include premedicating with a sedative or analgesic before surgery; using prophylactic (preventive) antibiotics before surgery; and using antiemetics or antihistamines before chemotherapy.
A 2024 systematic review of the literature found that chemoradiation with 5-FU and mitomycin C, as used in the Nigro Protocol, improves outcomes like colostomy-free survival in anal cancer patients compared to alternatives like cisplatin. However, it can lead to more severe side effects, especially blood-related toxicity. [7]
Nimotuzumab (h-R3, [2] BIOMAb EGFR, Biocon, India; [3] TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was ...
Duvortuxizumab (INN [1]) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies. [ 2 ] This drug was developed by Janssen Global Services.
This monoclonal antibody –related article is a stub. You can help Wikipedia by expanding it.
Panitumumab, sold under the brand name Vectibix, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
Ad
related to: cetuximab premedication protocol pdf version download free pc 1 19 windows 10